Mitochondria pp 151-166 | Cite as

Amino Acids and the Mitochondria

  • Nicola King
Part of the Advances in Biochemistry in Health and Disease book series (ABHD, volume 2)


This chapter describes some of the important physiological functions of amino acids in the mitochondria and the alterations caused by specific pathologies. To some extent all of the featured items are dependent upon the movement of amino acids across the highly selective permeability barrier that is the inner mitochondrial membrane. The performance of this transport by specific carriers is the subject of the first section. Once inside the mitochondrial matrix the amino acids become involved in a bewildering number of critical metabolic pathways. The second section elaborates on two of the most significant namely: the malateaspartate shuttle essential for the transfer of reducing equivalents between the cytoplasm and the mitochondria; and the urea cycle, which is responsible for maintaining sub-toxic levels of ammonia. The final section covers the changes to mitochondrial amino acid metabolism that occur under different pathological conditions. In this case three examples have been chosen comprising ischemiareperfusion in heart, myocardial hypertrophy and the special relationship that exists between glutamine and cancer cells.


Urea Cycle Excitatory Amino Acid Transporter Cardiac Mitochondrion Argininosuccinate Synthetase Amino Acid Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atlante A, Passarella S, Pierro P, Quagliariello E (1994) Proline transport in rat kidney mitochondria. Arch Biochem Biophys 309:139–148CrossRefPubMedGoogle Scholar
  2. Baggio R, Emig FA, Christianson DW, Ash DE, Chakdar S, Rattan S (1999) Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J Pharmacol Exp Therapeut 290:1409–1416Google Scholar
  3. Bittl JA, Shine KI (1983) Protection of ischemic rabbit myocardium by glutamic acid. Am J Physiol 245:H406–H412PubMedGoogle Scholar
  4. Borst P (1963) Hydrogen transport and transport metabolisms. In Karlson, P. (ed.), Functionelle und Morphologische Organisation der Zelle, Springer-Verlag, Berlin, pp. 137–158Google Scholar
  5. Bradford NM, McGivan JD (1973) Quantitative aspects of glutamate transport in rat liver mitochondria. Biochem J 134:1023–1029PubMedGoogle Scholar
  6. Buckberg GD (1996) Invited editorial on “Effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest”. J Thorac Cardiovasc Surg 112:1661–1663.CrossRefPubMedGoogle Scholar
  7. Butterworth RF (2001) Glutamate transporter and receptor function in disorders of ammonia metabolism. Ment Retard Dev Disabil Res Rev 7:276–279CrossRefPubMedGoogle Scholar
  8. Cheung CW, Raijman L (1981) Arginine, mitochondrial arginase, and the control of carbamyl phosphate synthesis. Arch Biochem Biophys 209:643–649CrossRefPubMedGoogle Scholar
  9. Colleluori DM, Morris SM Jr, Ash DE (2001) Expression purification and characterization of human type II arginase. Archiv Biochem Biophys 389:135–143CrossRefGoogle Scholar
  10. Dolinska M, Albrecht J (1998) L-Arginine uptake in rat cerebral mitochondria. Neurochem Int 33:233–236CrossRefPubMedGoogle Scholar
  11. Eagle H, Barban S, Levy M, Schulz HO (1958) Utilization of carbohydrates by human cell cultures. J Biol Chem 233:551–558PubMedGoogle Scholar
  12. Eigenbrodt E, Kallinowski F, Ott M, Mazurek S, Vaupel P (1998) Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res 18:3267–3274PubMedGoogle Scholar
  13. El Alaoui-Talibi Z, Moravec J (1989) Limitation of long chain fatty acid oxidation in volume over-loaded rat hearts. Adv Exp Med Biol 248:491–497PubMedGoogle Scholar
  14. Fiermonte G, Palmieri L, Todisco S, Agrimi G, Palmieri F, Walker JE (2002) Identification of the mitochondrial glutamate transporter. J Biol Chem 277: 19289–19294CrossRefPubMedGoogle Scholar
  15. Gómez-Fabre PM, Aledo JC, Del Castillo-Olivares A, Alonso FJ, Núñezde Castro I, Campos JA, Márquez J (2000) Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem J 345:365–375CrossRefPubMedGoogle Scholar
  16. Griffiths JR (2001) Causes and consequences of hypoxia and acidity in tumor microenvironments. Bioessays 23:295–296CrossRefPubMedGoogle Scholar
  17. Haas GS, DeBoer LWV, O’Keefe DD, Bodenhamer RM, Geffin MB, Drop LJ, Teplick RS, Daggett WM (1984) Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion. Circ 70(suppl I):I-65–I73Google Scholar
  18. Hacker HJ, Steinberg P, Bannasch P (1998) Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 19:99-107CrossRefPubMedGoogle Scholar
  19. Husson A, Brasse-Lagnel C, Fairand A, Renouf S, Lavoinne A (2003) Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 270:1887–1899CrossRefPubMedGoogle Scholar
  20. Hutson SM, Fenstermacher D, Mahar C (1988) Role of mitochondrial transamination in branched chain amino acid metabolism. J Biol Chem 263:3618–3625PubMedGoogle Scholar
  21. Hutson SM, Sweatt AJ, LaNoue KF (2005) Branched-chain amino acid metabolism: Implications for establishing safe intakes. J Nutr 135:1557S–1564SPubMedGoogle Scholar
  22. Iacobazzi V, Palmieri F, Runswick MJ, Walker JE (1992) Sequences of the human and bovine genes for the mitochondrial 2-oxoglutarate gene. DNA Seq 3:79–88CrossRefPubMedGoogle Scholar
  23. Ibsen KH (1977) Interrelationships and functions of the pyruvate kinase isoenzymes and their variant forms: a review. Cancer Res 37:341–353PubMedGoogle Scholar
  24. Indiveri C, Abruzzo G, Stipani I, Palmieri F (1998) Identification and purification of the reconstitutively active glutamine carrier from rat kidney mitochondria. Biochem J 333:285–290PubMedGoogle Scholar
  25. Jungas RL, Halperin ML, Brosnan JT (1992) Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev 72:419–448PubMedGoogle Scholar
  26. Kanai Y, Hediger MA (2004) The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflügers Archiv 447:469–479CrossRefPubMedGoogle Scholar
  27. Kaplan RS (2001) Structure and function of mitochondrial anion transport proteins. J Membrane Biol 179:165–183CrossRefGoogle Scholar
  28. King N, Lin H, McGivan JD, Suleiman MS (2004) Aspartate transporter activity in hypertrophic rat heart and ischaemia-reperfusion injury. J Physiol 556: 849–858CrossRefPubMedGoogle Scholar
  29. King N, McGivan JD, Griffiths EJ, Halestrap AP, Suleiman MS (2003) Glutamate loading protects freshly isolated and perfused adult rat cardiomyocytes from intracellular ROS generation. J Mol Cell Cardiol 35: 975–984CrossRefPubMedGoogle Scholar
  30. King N, Suleiman MS (2001) L-Leucine transport in rat heart under normal conditions and effect of simulated hypoxia. Mol Cell Biochem 221: 99–108CrossRefPubMedGoogle Scholar
  31. King N, Williams H, McGivan JD, Suleiman MS (2001) Characteristics of L-aspartate transport and expression of EAAC-1 in sarcolemmal vesicles and isolated cells from rat heart. Cardiovasc Res 52: 84–94CrossRefPubMedGoogle Scholar
  32. Kugler P (2004) Expression of glutamate transporters in rat cardiomyocytes and their localization in the T-tubular system. J Histochem. Cytochem 52:1385–1392CrossRefPubMedGoogle Scholar
  33. LaNoue KF, Tischler ME (1974) Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter. J Biol Chem 249:7522–7528PubMedGoogle Scholar
  34. LaNoue KF, Schoolwerth AC (1979) Metabolite transport in mitochondria. Ann Rev Biochem 48:871–922CrossRefPubMedGoogle Scholar
  35. Lazar HL, Buckberg GD, Manganaro AM, Becker H (1980) Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg 80:350–359PubMedGoogle Scholar
  36. Lehninger AL (1951) Phosphorylation coupled to oxidation of dihydrodi-phosphopyridine nucleotide. J Biol Chem 190:345–359PubMedGoogle Scholar
  37. Linder-Horowitz M, Knox WE, Morris HP (1969) Glutaminase activities and growth rates of rat hepatomas. Cancer Res 29:1195–1199PubMedGoogle Scholar
  38. Mathews CK, Van Holde KE (1990) Biochemistry. Benjamin Cummings Publishing Company, Redwood City, CaliforniaGoogle Scholar
  39. McKeehan WL (1982) Glycolysis, glutaminolysis and cell-proliferation. Cell Biol Int Rep 6: 635–650CrossRefPubMedGoogle Scholar
  40. Medina MA (2001) Glutamine and cancer. J Nutr 131:2539S–2542SPubMedGoogle Scholar
  41. Medina MA, Sánchez-Jiménez F, Márquez J, Queseda AR, Núñez de Castro I (1992) Relevance of glutamine metabolism to tumor cell growth. Mol Cell Biochem 113:1–15CrossRefPubMedGoogle Scholar
  42. Montessuit C, Thorburn A (1999) Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiomyocytes by hypertrophic agonists. J Biol Chem 274: 9006–9012CrossRefPubMedGoogle Scholar
  43. Nissim I, Luhovyy B, Horyn O, Daihin Y, Nissim I, Yudkoff M (2005) The role of mitochondrially bound arginase in the regulation of urea synthesis. J Biol Chem 280:17715–17724CrossRefPubMedGoogle Scholar
  44. Palmieri L, Pardo B, Lasorsa FM, Del Arco A, Kobayashi K, Lijima M, Runswick MJ, Walker JE, Saheki T, Satrústegui J, Palmieri F (2001) Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060–5069CrossRefPubMedGoogle Scholar
  45. Paquette JC, Guérin PJ, Gauthier ER (2004) Rapid induction of the intrinsic apoptotic pathway by glutamine starvation. J Cell Physiol 202:912–921CrossRefGoogle Scholar
  46. Passarella S, Atlanate A, Valenti D, De Bari L (2003) The role of mitochondrial transport in energy metabolism. Mitochondrion 2:319–343CrossRefPubMedGoogle Scholar
  47. Pisarenko OI (1996) Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Exptl Pharmacol 23:627–633CrossRefGoogle Scholar
  48. Pisarenko OI, Novikova EB, Serebryakova LI, Tskitishvili OV, Ivanov VE, Studneva IM (1985) Function and metabolism of dog heart in ischaemia and in subsequent reperfusion: effect of exogenous glutamic acid. Pflügers Archiv 405:377–383CrossRefPubMedGoogle Scholar
  49. Pisarenko OI, Studneva IM, Shulzhenko VS, Korchazhkina OV, Kapelko VI (1995) Substrate accessibility to cytosolic aspartate aminotransferase improves posthypoxic recovery of isolated rat heart. Biochemical Mol Med 55:138–148CrossRefGoogle Scholar
  50. Porter RK (2000) Mammalian mitochondrial inner membrane cationic and neutral amino acid carriers. Biochim Biophys Acta 1459:356–362CrossRefPubMedGoogle Scholar
  51. Queseda AR, Sánchez-Jiménez F, Perez-Rodriguez J, Márquez J, Medina MA, Núñez de Castro I (1988) Purification of phosphate-dependent glutaminase from isolated mitochondria of Ehrlich ascites tumor cells. Biochem J 255:1031–1036Google Scholar
  52. Ralphe JC, Bedell K, Segar JL, Scholz TD (2005) Correlation between myocardial malate/aspartate shuttle activity and EAAT1 protein expression in hyper- and hypothyroidism. Am J Physiol. 288:H2521–H2526Google Scholar
  53. Ralphe JC, Segar JL, Schutte BC, Scholz TD (2004) Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria. J Mol Cell Cardiol 37:33–41CrossRefPubMedGoogle Scholar
  54. Reitzer LJ, Wice BM, Kennell D (1979) Evidence that glutamine, not glucose, is the main energy-source for Hela-cells. J Biol Chem 254:2669–2676PubMedGoogle Scholar
  55. Rossi A, Lortet S (1996) Energy metabolism patterns in mammalian myocardium adapted to chronic pathophysiological conditions. Cardiovasc Res 31:163–171PubMedGoogle Scholar
  56. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA (2004) Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985–993CrossRefPubMedGoogle Scholar
  57. Safer B (1975) The metabolic significance of the malate-aspartate cycle in heart. Circ Res 37, 527–533PubMedGoogle Scholar
  58. Scholz TD, TenEyck CJ, Schutte BC (2000) Thyroid hormone regulation of the NADH shuttles in liver and cardiac mitochondria. J Mol Cell Cardiol 32:1–10CrossRefPubMedGoogle Scholar
  59. Schwalb H, Yaroslavsky E, Borman JB, Uretzky G (1989) The effect of amino acids on the ischemic heart. J Thorac Cardiovasc Surg 98:551–556PubMedGoogle Scholar
  60. Seymour AML, Eldar H, Radda GK (1990) Hyperthyroidism results in increased glycolytic capacity in the rat heart. A 31P-NMR study. Biochim Biophys Acta 1055:107–116CrossRefPubMedGoogle Scholar
  61. Souba WW (1993) Glutamine and cancer. Ann. Surg 218:715–728CrossRefPubMedGoogle Scholar
  62. Suleiman MS, Halestrap AP, Griffiths EJ (2001) Mitochondria: a target for myocardial protection. Pharmacol Therapeut 89:29–46CrossRefGoogle Scholar
  63. Sveldjeholm R, Håkanson E, Vanhanen I (1995) Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery. Ann Thorac Surg 59:S15–S22CrossRefGoogle Scholar
  64. Taegtmeyer H (1995) Metabolic support for the postischaemic heart. Lancet 345:1552–1555CrossRefGoogle Scholar
  65. Townsend DM, Tew KD, Tapiero H (2004) Sulfur containing amino acids and human disease. Biomed Pharmacother 58:47–55CrossRefPubMedGoogle Scholar
  66. Valdares JRE, Singhai RL, Parulekar MR, Beznak M (1969) Influence of aortic coarctation on myocardial glucose-6-phosphate dehydrogenase. Can J Physiol Pharmacol47:388–391Google Scholar
  67. Williams H, King N, Griffiths EJ, Suleiman MS (2001) Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocytes. J Mol Cell Cardiol 33: 2109–2119CrossRefPubMedGoogle Scholar
  68. Williamson DH, Lund P, Krebs HA (1967) Redox state of free nicotinamide-adenine dinucleotide in cytoplasm and mitochondria of rat liver. Biochem J 103:514–527PubMedGoogle Scholar
  69. Wu GY, Morris SM (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336:1–17PubMedGoogle Scholar
  70. Yasuda T, Yamaguchi N, Kobayashi K, Nishi I, Horinouchi H, Jalil A, Li MX, Ushikai M, Lijima M, Kondo I, Saheki T (2000) Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinaemia. Hum Genet 107:537–545CrossRefPubMedGoogle Scholar
  71. Zweier JL (1988) Measurement of superoxide-derived free radicals in the reperfused heart. J Biol Chem 263:1353–1357PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Nicola King

There are no affiliations available

Personalised recommendations